IP Library Granted Patent US 8,073,549
Granted Patent B2
US 8,073,549 · App. 12/762,708 · Granted Dec 6, 2011

Method of electrogenically controlling pump molecules

Assignee: University of South Florida
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,073,549
App. No.
12/762,708
Granted
Dec 6, 2011
Kind
B2
Abstract

Activation of electrogenic pump molecules can be realized by a dynamic entrainment procedure which includes two steps: synchronization of individual pump molecules to work at the same pumping pace, and gradual modulation of the synchronization frequency. Na/K pump molecules were used as an example in a physiological operating mode by applying the concept of an electronic synchrotron to the biological system. It was shown that individual Na/K pump molecules can be synchronized by a well designed oscillating electric field. The synchronized pump currents show separated inward and outward pump currents and a magnitude ratio of 3:2 reflecting stoichiometric number of the pump molecules.

Claims (22)

1. A method of controlling the cycle of a plurality of carrier-mediated ion transporters comprising the steps of:

applying an oscillating electric field at a predetermined synchronization frequency wherein the frequency is substantially equal to the ion transporters initial natural turnover rate; and

incrementally adjusting the synchronization frequency to control the cycle.

2. The method of claim 1 wherein the carrier-mediated ion transporters have an ion-transport step that is the rate-limiting step to their respective reaction.

3. The method of claim 1 wherein the carrier-mediated ion transporters are sensitive to membrane potential.

4. The method of claim 1 wherein the magnitude of the oscillating electric field is restricted to a magnitude which allows the field-induced membrane potential to fall within the physiological range.

5. The method of claim 1 wherein the synchronization frequency of the oscillating electric field can be changed through changing oscillating cycle duration by applying continuous small changes in consecutive cycles or large incremental changes in repeating cycles.

6. The method of claim 5 wherein the changes in the oscillating cycle duration through applying small changes in consecutive cycles are about 1% or less of the cycle duration.

7. The method of claim 5 wherein the changes in the oscillating cycle duration through applying large incremental changes in repeating cycles are between about 3% and about 5% of the cycle duration.

8. The method of claim 5 wherein the maximum frequency incremental change is between half of the previous frequency and double the previous frequency.

9. The method of claim 5 wherein the maximum incremental change in the oscillating cycle is between half of the previous cycle duration and double the previous cycle duration.

10. The method of claim 1 wherein the turnover rate is reverse modulated when the synchronization frequency is gradually reduced.

11. A method of controlling the cycle of a plurality of Na/K pump molecules comprising the steps of:

applying an oscillating electric field at a predetermined synchronization frequency wherein the frequency is substantially equal to the pump molecules' initial natural turnover rate and;

incrementally adjusting the synchronization frequency to control the cycle.

12. The method of claim 11 wherein the magnitude of the oscillating electric field is restricted to a magnitude which allows the field-induced membrane potential to fall within the physiological range.

13. The method of claim 11 wherein the synchronization frequency of the oscillating electric field can be changed by changing pulse duration through applying continuous small changes in consecutive pulses or large incremental changes in repeating pulses.

14. The method of claim 13 wherein the changes in pulse duration by applying small changes in consecutive pulses are about 1% or less of the pulse duration.

15. The method of claim 13 wherein the changes in pulse duration by applying large incremental changes in repeating pulses are between about 3% and about 5% of the pulse duration.

16. The method of claim 13 wherein the maximum frequency incremental change is between half of the previous frequency and double the previous frequency.

17. The method of claim 13 wherein the maximum pulse duration is between half of the previous pulse duration and double the previous pulse duration.

18. The method of claim 11 wherein the pumping rate is reverse modulated when synchronization frequency is gradually reduced.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 24, 2012
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027580/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2010
From: CHEN, WEI
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 024607/0355 →
CONFIRMATORY LICENSE Recorded Jun 21, 2010
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024564/0005 →
Continuity (4)
Continuation In Part 12231030 · Aug 28, 2008
Continuation PCTUS2007005200 · Feb 28, 2007
Provisional Application 60767045 · Feb 28, 2006
Related Publication 20100249757A1 · Sep 30, 2010